NeuroMetrix submits regulatory application for NC-stat DPNCheck in China NeuroMetrix reported the regulatory submission for NC-stat DPNCheck in China. The submission was prepared in close collaboration with Omron Healthcare, NeuroMetrix’ partner for NC-stat DPNCheck in China and other Asia markets. The submission seeks registration as a Class II Medical Device as defined in the Regulations for the Supervision and Administration of Medical Devices administered by the China Food and Drug Administration. Clearance of the submission will allow NC-stat DPNCheck to be marketed within China.
News For NURO From The Last 14 Days
Check below for free stories on NURO the last two weeks.